Phospho-β-catenin accumulation in Alzheimer's disease and in aggresomes attributable to proteasome dysfunction

被引:56
作者
Ghanevati, M
Miller, CA [1 ]
机构
[1] Univ So Calif, Keck Sch Med, Dept Pathol, Los Angeles, CA 90033 USA
[2] Univ So Calif, Keck Sch Med, Dept Neurol, Los Angeles, CA 90033 USA
[3] Univ So Calif, Keck Sch Med, Program Neurosci, Los Angeles, CA 90033 USA
关键词
Aggresome; Alzheimer's disease; granulovacuolar degeneration; phospho-beta-catenin; proteasome;
D O I
10.1385/JMN:25:1:079
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Accumulation of cytoplasmic inclusion bodies in many neurodegenerative diseases, including Alzheimer's disease (AD), might result from dysfunction of the ubiquitin-proteasome system. This system degrades many cellular proteins, including beta-catenin, a member of the Wnt signaling pathway, and a presenilin-1-interacting protein. Phosphorylation of beta-catenin marks it for ubiquitination and rapid proteasomal degradation. We found phospho-beta-catenin accumulated as detergent-insoluble, punctate, cytoplasmic inclusions in hippocampal pyramidal neurons more abundantly in AD than in aged controls. In AD, beta-catenin was ubiquitin conjugated, thus suggesting impaired proteasome-dependent degradation. Phospho-beta-catenin was partially sequestered within granulovacuolar degeneration bodies but not in lysosomes, indicating sequestration within autophagosomes. Exposure of neuronal cultures to proteasome inhibitors induced formation of detergent-insoluble, phospho-beta-catenin-positive cytoplasmic inclusions that coalesced into aggresomes and colocalized with gamma-tubulin and vimentin These aggregates were associated with apoptotic cell death and with activation of caspase-3, c-Jun-N-terminal kinases, and c-Jun. These findings suggest that phospho-beta-catenin accumulation in AD might result from impaired proteasome function.
引用
收藏
页码:79 / 94
页数:16
相关论文
共 62 条
[21]   The F-box protein β-TrCP associates with phosphorylated β-catenin and regulates its activity in the cell [J].
Hart, M ;
Concordet, JP ;
Lassot, I ;
Albert, I ;
del los Santos, R ;
Durand, H ;
Perret, C ;
Rubinfeld, B ;
Margottin, F ;
Benarous, R ;
Polakis, P .
CURRENT BIOLOGY, 1999, 9 (04) :207-210
[22]   Ubiquitin-dependent protein degradation [J].
Hochstrasser, M .
ANNUAL REVIEW OF GENETICS, 1996, 30 :405-439
[23]   Editorial on consensus recommendations for the postmortem diagnosis of Alzheimer disease from the National Institute on Aging and the Reagan Institute working group on diagnostic criteria for the neuropathological assessment of Alzheimer disease [J].
Hyman, BT ;
Trojanowski, JQ .
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1997, 56 (10) :1095-1097
[24]   Parkin suppresses unfolded protein stress-induced cell death through its E3 ubiquitin-protein ligase activity [J].
Imai, Y ;
Soda, M ;
Takahashi, R .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (46) :35661-35664
[25]   Cytoplasmic dynein/dynactin mediates the assembly of aggresomes [J].
Johnston, JA ;
Illing, ME ;
Kopito, RR .
CELL MOTILITY AND THE CYTOSKELETON, 2002, 53 (01) :26-38
[26]   Aggresomes: A cellular response to misfolded proteins [J].
Johnston, JA ;
Ward, CL ;
Kopito, RR .
JOURNAL OF CELL BIOLOGY, 1998, 143 (07) :1883-1898
[27]   Parkin accumulation in aggresomes due to proteasome impairment [J].
Junn, E ;
Lee, SS ;
Suhr, UT ;
Mouradian, MM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (49) :47870-47877
[28]   Impaired proteasome function in Alzheimer's disease [J].
Keller, JN ;
Hanni, KB ;
Markesbery, WR .
JOURNAL OF NEUROCHEMISTRY, 2000, 75 (01) :436-439
[29]   Proteasome inhibition by the natural products epoxomicin and dihydroeponemycin: Insights into specificity and potency [J].
Kim, KB ;
Myung, J ;
Sin, N ;
Crews, CM .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1999, 9 (23) :3335-3340
[30]   Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism [J].
Kitada, T ;
Asakawa, S ;
Hattori, N ;
Matsumine, H ;
Yamamura, Y ;
Minoshima, S ;
Yokochi, M ;
Mizuno, Y ;
Shimizu, N .
NATURE, 1998, 392 (6676) :605-608